![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
01 Fresenius Kabi AB Brunna (2)
02 GSK (11)
03 LA.FA.RE. Srl (1)
04 Laboratoires Théa S.A.S (1)
05 MALESCI SpA IST.FARMACOBIOL. (1)
06 MIP Pharma (2)
07 ORIFARM GROUP AS (1)
08 Sandoz B2B (2)
09 Stragen Pharma SA (3)
10 TECNOPHARMA Srl (1)
11 Villerton Invest Said (3)
01 Cefuroxime Sodium (28)
01 Italy (7)
02 Norway (15)
03 Switzerland (6)
01 Cefuroxime 1.000Mg 1 Unit Parenteral Use (2)
02 Cefuroxime 250Mg/5Ml 50Ml Oral Use (1)
03 Cefuroxime 500Mg 2Ml 1 Units Parenteral Use (1)
04 Injectable (5)
05 Powder for injection fluid, resolution (3)
06 Powder for injection fluid, suspension or resolution (2)
07 Powder for injection/infusion fluid (4)
08 Powder for injection/infusion fluid, resolution (6)
09 Suspension (1)
10 Blank (3)